Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Joseph McCune

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Arthritis and Rheumatism|August 29, 2009
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosusDaniel J Wallace, William Stohl, Richard A Furie, et al.
The Journal of Rheumatology|June 19, 2012
Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trialW Winn Chatham, Daniel J Wallace, William Stohl, et al.
The Journal of Rheumatology|October 9, 2007
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic eventJodi K Sebastian, Barbara Voetsch, John H Stone, et al.
Arthritis and Rheumatism|June 30, 2005
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)Philip Seo, Yuan-I Min, Janet T Holbrook, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 27, 2018
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated VasculitisRennie L Rhee, John C Davis, Linna Ding, et al.
Annals of Internal Medicine|November 3, 2007
Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosisJavier D Finkielman, Peter A Merkel, Darrell Schroeder, et al.
Arthritis Care & Research|December 1, 2011
Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)Megan E B Clowse, Susannah C Copland, Tsung-Cheng Hsieh, et al.
Arthritis and Rheumatism|April 29, 2006
Solid malignancies among patients in the Wegener's Granulomatosis Etanercept TrialJohn H Stone, Janet T Holbrook, Matthew A Marriott, et al.
Arthritis Care & Research|April 1, 2011
A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitisRavi Suppiah, Andrew Judge, Rajbir Batra, et al.
The American Journal of Medicine|July 3, 2007
ANCA are detectable in nearly all patients with active severe Wegener's granulomatosisJavier D Finkielman, Augustine S Lee, Amber M Hummel, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Arthritis and Rheumatism|August 29, 2009
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosusDaniel J Wallace, William Stohl, Richard A Furie, et al.
The Journal of Rheumatology|June 19, 2012
Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trialW Winn Chatham, Daniel J Wallace, William Stohl, et al.
The Journal of Rheumatology|October 9, 2007
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic eventJodi K Sebastian, Barbara Voetsch, John H Stone, et al.
Arthritis and Rheumatism|June 30, 2005
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)Philip Seo, Yuan-I Min, Janet T Holbrook, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 27, 2018
The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated VasculitisRennie L Rhee, John C Davis, Linna Ding, et al.
Annals of Internal Medicine|November 3, 2007
Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosisJavier D Finkielman, Peter A Merkel, Darrell Schroeder, et al.
Arthritis Care & Research|December 1, 2011
Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)Megan E B Clowse, Susannah C Copland, Tsung-Cheng Hsieh, et al.
Arthritis and Rheumatism|April 29, 2006
Solid malignancies among patients in the Wegener's Granulomatosis Etanercept TrialJohn H Stone, Janet T Holbrook, Matthew A Marriott, et al.
Arthritis Care & Research|April 1, 2011
A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitisRavi Suppiah, Andrew Judge, Rajbir Batra, et al.
The American Journal of Medicine|July 3, 2007
ANCA are detectable in nearly all patients with active severe Wegener's granulomatosisJavier D Finkielman, Augustine S Lee, Amber M Hummel, et al.
Pageof 9